|
| | Issue Date | Title | Author(s) |
| 1 | 15-Apr-2023 | A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies | Chee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher |
| 2 | 1-Aug-2012 | Awaiting a new era of cancer immunotherapy | Hong, C.W.; Zeng, Q. |
| 3 | Feb-2012 | Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice | Guo, K.; Tang, J.P.; Jie, L.; Al-Aidaroos, A.Q.O.; Hong, C.W.; Tan, C.P.B.; Park, J.E.; Varghese, L.; Feng, Z.; Zhou, J. ; Chng, W.J.; Zeng, Q. |
| 4 | 1-Aug-2013 | Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells | Al-Aidaroos, A.Q.O.; Yuen, H.F.; Guo, K.; Zhang, S.D.; Chung, T.-H. ; Chng, W.J.; Zeng, Q. |
| 5 | 1992 | Neuropeptide gene expression in transgenic animals | Murphy, D. ; Ang, H.-L. ; Zeng, Q. ; Ho, M.-Y. ; Funkhouser, J. ; Carter, D. |
| 6 | Sep-2013 | Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia | Park, J.E.; Yuen, H.F.; Zhou, J.B. ; Al-aidaroos, A.Q.O.; Guo, K.; Valk, P.J.; Zhang, S.D.; Chng, W.J.; Hong, C.W.; Mills, K.; Zeng, Q. |
| 7 | 1-Dec-2010 | PRL-3 phosphatase and cancer metastasis | Al-Aidaroos, A.Q.O.; Zeng, Q. |
| 8 | 18-Feb-2013 | PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells | Liu, H.; Al-aidaroos, A.Q.O.; Wang, H.; Guo, K.; Li, J.; Zhang, H.F.; Zeng, Q. |
| 9 | 29-Apr-1993 | Regulation of the extent of polyadenylation of vasopressin and growth hormone mRNAs in response to physiological stimuli | Waller, S.J. ; Carter, D.A. ; Ang, H.-L. ; Ho, M.-Y. ; Zeng, Q. ; Murphy, D. |
| 10 | 21-Jan-2014 | Tapping the treasure of intracellular oncotargets with immunotherapy | Hong, C.W.; Zeng, Q. |
| 11 | 7-Sep-2011 | Targeting intracellular oncoproteins with antibody therapy or vaccination | Guo, K.; Li, J.; Tang, J.P.; Tan, C.P.B.; Hong, C.W.; Al-Aidaroos, A.Q.O.; Varghese, L.; Huang, C.; Zeng, Q. |
